简介内容:Arylquin 1, a prostate-apoptosis-response-4 (Par-4) secretagogue, specifically targets vimentin to facilitate Par-4 secretion. Additionally, it promotes non-apoptotic cell death in cancer cells by inducing lysosomal membrane permeabilization (LMP) [1].